Navigation Links
A new route for tackling treatment-resistant prostate cancer
Date:7/24/2012

Scientists have identified what may be the Peyton Manning of prostate cancer. It's a protein that's essential for the disease to execute its game plan: Grow and spread throughout the body.

Like any good quarterback, this protein has command over the entire field; not only does it control cell growth in tumors that are sensitive to hormone therapy, a common treatment for men with advanced disease, but also in tumors that grow resistant to such treatment a dismal development that leaves men and their doctors with no good options to turn to.

In a study published in the Journal of Clinical Investigation, a team led by scientists from the University of Rochester Medical Center found that the protein paxillin is a major player in prostate cancer, the second most common form of cancer in men. Though in the very early stages, the discovery is an important first step towards developing a treatment for men whose cancer prevails even after the most aggressive treatment.

"The holy grail in prostate cancer is to figure out why cells stop responding to hormone therapy," said senior study author Stephen R. Hammes, M.D., Ph.D., chief of the Division of Endocrinology and Metabolism at the Medical Center. Initially, hormone therapy, which starves tumors of the hormones that fuel their growth, works well and may lead to remission. But, according to the American Cancer Society, nearly all prostate cancers treated with hormone therapy become resistant over a period of months or years and the cancer makes an unwelcome comeback.

"Somehow, tumors find a way to grow even when their main power source is choked off," noted Hammes, also the Louis S. Wolk Distinguished Professor in Medicine. "Our work is exciting because we've identified a protein pathway that controls growth even in the absence of hormones and provides a completely new treatment target for the disease."

Hammes and first author Aritro Sen, Ph.D., Research Assistant
'/>"/>

Contact: Emily Boynton
emily_boynton@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel drug candidates offer new route to controlling inflammation
2. Doubling down on heart failure: Researchers discover new route to disease, and drugs to match
3. New roadmap suggests proven routes to ending health disparities
4. New drug prevents spread of human prostate cancer cells
5. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
6. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
7. Study examines adverse effects among different radiation therapies for prostate cancer
8. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
9. Warren Buffett Has Early Stage Prostate Cancer
10. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
11. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Prime Pacific Health Innovations, the ... announce a new series of universal, one-time-use speculum ... footprint while improving treatment efficacy and saving therapists ... the world’s first waste hose designed specifically for ... claims the company’s president, Mr. Delmar Vogel. , ...
(Date:5/6/2015)... Animals make just as good friends as they do pets. ... An Ohio veterinarian has been observing this for ... advantages of owning a pet. , “When animals and humans ... there are proven health benefits for people-- including physical, mental ... Animal Medical Center of Streetsboro said. Every May, ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Inversion ... specializes in yoga and Pilates classes, provides personalized ... and products, starting with its new Pilates Ring ... effort of becoming leaner, stronger, more centered and ... offer a fresh venue to healthy fitness through ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Wolters ... healthcare professionals and students, announced today that in a ... confirmed that use of the clinical decision support resource ... the end of 2014, UpToDate users in more than ... topics per month, on average. In Germany alone, 95% ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 In March, ... presenting at the 8th Milano Masterclass. As Europe’s most ... most elite plastic surgeons. Dr. Batniji was hand chosen ... Facial Plastic and Reconstructive Surgery, Dr. Pietro Palma. ... Milan, Italy. The conference hosts a diverse, multi-national faculty; ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:California Surgeon Speaks at International Rhinoplasty Conference 2
... Karzin donated half his liver to his mother-in-law in November ... life of his wife’s mother and his children’s grandmother. ... represent Cedars-Sinai Medical Center on the Donate Life Rose Parade? ... be an honor, and I think it’s important because word ...
... warned that many children //are coming down with Kidney stones ... Neu, co-director of the kidney stone clinic at the Children's ... coming to us. While this is somewhat unexpected, it is ... on the rise in children due to poor diet, such ...
... not be a good day after all to visit a hospital, ... the hospital.// ,The Institute for Public Policy Research (IPPR), ... blamed the procedures in the NHS for the undue delays for ... be. ,It was found that an estimated 180,000 people ...
... Thursday, elderly persons who had failed to receive information on ... insurance by Medicare, will be given an extra time period ... ,The Health Care Financing Administration, U.S. of the ... ,Medicare is the primary federal health care program ...
... increase the risk of painful inflammation of the pancreas, ... Singh, M.D., from Wake Forest University School of Medicine, ... condition and cholesterol-lowering drugs have been implicated in some ... world take these drugs, our aim was to quantify ...
... shown that GlaxoSmithKline's Tykerb along with Roche's Xeloda is ... positive advanced breast cancer, where the disease had progressed ... findings, researchers opined that, Tykerb should be checked out ... positive breast cancer. ,"Patients with advanced or ...
Cached Medicine News:Health News:Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade 2Health News:Living Liver Donor Who Saved Life of Mother-in-law Represents Cedars-Sinai in Rose Parade 3Health News:Risk of Acute Pancreatitis Low With Statins 2
(Date:5/6/2015)... BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today reported ... Total revenues for the first quarter ... $136.8 million in the first quarter of 2014. Revenues ... million in royalty and license payments from PDL,s licensees ... net royalty payments from acquired royalty rights and a ...
(Date:5/6/2015)... Company, Inc. (NYSE: LCI ) today reported financial ... 31, 2015.  For the fiscal 2015 ... from $80.0 million in last year,s third quarter.  Gross ... net sales, from $56.1 million, or 70% of net ... million from $10.6 million for the fiscal 2014 third ...
(Date:5/6/2015)... BETHESDA, Md. , May 6, 2015 ... announced that it has finalized agreement with Richard ... through 2021. "We are very pleased to ... and CEO," said Hal Baseman , the Chair ... enjoyed significant success, performance and growth.  Richard has led ...
Breaking Medicine Technology:PDL BioPharma Announces First Quarter 2015 Financial Results 2PDL BioPharma Announces First Quarter 2015 Financial Results 3PDL BioPharma Announces First Quarter 2015 Financial Results 4PDL BioPharma Announces First Quarter 2015 Financial Results 5PDL BioPharma Announces First Quarter 2015 Financial Results 6PDL BioPharma Announces First Quarter 2015 Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2
... by Dr. Earl Crouch ... for corneal and scleral ... to rest on the ... cornea. Easily removed with ...
Used with eye shield to cushion the eye. Eliminates need for taping shield. No sticky residue. Package 50 per box. Assorted colors....
Includes one aluminum pediatric eye shield and one eye garter shield cover. Packaged 50 per box. White only....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Medicine Products: